ARCH Venture Partners IX, LLC - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ARCH Venture Partners IX, LLC since 24 Feb 2025

Holdings reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 910,317 $4,271,389 $4.69 25 Jul 2025 By ARCH Venture Fund IX, L.P.
Common Stock 910,317 $4,271,389 $4.69 25 Jul 2025 By ARCH Venture Fund IX Overage, L.P.

Transactions reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.